Skip to main content

Eli Lilly and Company Verzenio revenue

  • LLY · NYSE
  • Pharmaceuticals
  • S&P 500
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.36T

Verzenio revenue at Eli Lilly and Company came to $897.0M for the quarter to 30 Sep 2026, up 1.9% from a year earlier.

As Eli Lilly and Company reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$774.8MDec 2023$638.2MMar 2024$861.4MJun 2024$878.8MSep 2024$1.0BDec 2024$658.0MMar 2025$929.0MJun 2025$880.0MSep 2025$997.0MDec 2025$706.0MMar 2026$845.0MJun 2026$897.0MSep 2026
Eli Lilly and Company Verzenio revenue, every reported period
Period endingVerzenio revenueChange on a yearFiled
30 Sep 2026$897.0Mup 1.9%29 Oct 2026
30 Jun 2026$845.0Mdown 9.0%5 Aug 2026
31 Mar 2026$706.0Mup 7.3%30 Apr 2026
31 Dec 2025$997.0Mdown 4.3%12 Feb 2026
30 Sep 2025$880.0Mup 0.1%30 Oct 2025
30 Jun 2025$929.0Mup 7.8%7 Aug 2025
31 Mar 2025$658.0Mup 3.1%1 May 2025
31 Dec 2024$1.0Bup 34.5%19 Feb 2025
30 Sep 2024$878.8Mup 28.4%30 Oct 2024
30 Jun 2024$861.4Mup 46.3%8 Aug 2024
31 Mar 2024$638.2Mup 38.4%30 Apr 2024
31 Dec 2023$774.8Mup 40.2%21 Feb 2024
30 Sep 2023$684.6Mup 65.0%2 Nov 2023
30 Jun 2023$588.6Mup 53.2%8 Aug 2023
31 Mar 2023$461.1Mup 52.9%27 Apr 2023
31 Dec 2022$552.7Mup 118.6%22 Feb 2023
30 Sep 2022$414.8Mup 107.8%1 Nov 2022
30 Jun 2022$384.3Mup 83.3%4 Aug 2022
31 Mar 2022$301.5Mup 74.5%29 Apr 2022
31 Dec 2021$252.8Mup 34.3%23 Feb 2022
30 Sep 2021$199.6Mup 25.6%27 Oct 2021
30 Jun 2021$209.7Mup 48.0%3 Aug 2021
31 Mar 2021$172.8Mup 33.5%30 Apr 2021
31 Dec 2020$188.2Mup 43.3%17 Feb 2021
30 Sep 2020$158.9Mup 27.3%28 Oct 2020
30 Jun 2020$141.7Mup 34.7%31 Jul 2020
31 Mar 2020$129.4Mup 38.4%1 May 2020
31 Dec 2019$131.3Mup 71.4%19 Feb 2020
30 Sep 2019$124.8Mup 47.7%25 Oct 2019
30 Jun 2019$105.2Mup 82.3%2 Aug 2019
31 Mar 2019$93.5Mup 214.8%2 May 2019
31 Dec 2018$76.6M—19 Feb 2019
30 Sep 2018$84.5M—6 Nov 2018
30 Jun 2018$57.7M—25 Jul 2018
31 Mar 2018$29.7M—27 Apr 2018

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Eli Lilly and Company: Cardiometabolic Health revenue · Zepbound revenue · Mounjaro revenue · Oncology revenue · Immunology revenue · Jardiance revenue · Trulicity revenue · Taltz revenue · Neuroscience revenue · United States revenue · Outside U.S. revenue · Europe revenue · Rest of world revenue · China revenue · Japan revenue · financial statements

Every KPI and segment of LLY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.